The downregulation found in the three studies reviewed, one in severe COVID-19, could indicate an increase of MMP-9 in these patients prompting long term consequences in the PNS, leading to the appearance of peripheral pain (Figure 3). The gene discussed is MMP9; the disease is COVID-19.